The COVID-19 pandemic and its effects on follow-up of patients with early breast cancer: A patient survey.
Breast cancer
Follow-up
Patient survey
Survivorship
Journal
Breast cancer research and treatment
ISSN: 1573-7217
Titre abrégé: Breast Cancer Res Treat
Pays: Netherlands
ID NLM: 8111104
Informations de publication
Date de publication:
09 Jan 2024
09 Jan 2024
Historique:
received:
27
04
2023
accepted:
14
12
2023
medline:
9
1
2024
pubmed:
9
1
2024
entrez:
9
1
2024
Statut:
aheadofprint
Résumé
Despite limited evidence supporting its effectiveness, most guidelines recommend long-term, routinely scheduled in-person surveillance of patients with early breast cancer (EBC). The COVID-19 pandemic led to increased use of virtual care. This survey evaluated patient perspectives on follow-up care. Patients with EBC undergoing surveillance were surveyed about follow-up protocols, perceptions, and interest in clinical trials assessing different follow-up strategies. Of 402 approached patients 270 completed the survey (response rate 67%). Median age 62.5 years (range 25-86) and median time since breast cancer diagnosis was 3.8 years (range < 1-33 years). Most (n = 148/244, 60%) were followed by more than one provider. Routine follow-ups with breast examination were mostly conducted by medical/radiation oncologists every 6 months (n = 110/236, 46%) or annually (n = 106/236, 44%). Participants felt routine follow-up was useful to monitor for recurrence, manage side effects of cancer treatment and to provide support/reassurance. Most participants felt regular follow-up care would detect recurrent cancer earlier (n = 214/255, 96%) and increase survival (n = 218/249, 88%). The COVID-19 pandemic reduced the number of in-person visits for 54% of patients (n = 63/117). Patients were concerned this reduction of in-person visits would lead to later detection of both local (n = 29/63, 46%) and distant recurrences (n = 25/63, 40%). While many felt their medical and radiation oncologists were the most suited to provide follow-up care, 55% felt comfortable having their primary care provider (PCP) conduct surveillance. When presented with a scenario where follow-up has no effect on earlier detection or survival, 70% of patients still wanted routine in-person follow-up for reassurance (63%) with the goal of earlier recurrence detection (56%). Despite limited evidence of effectiveness of routine in-person assessment, patients continue to place importance on regularly scheduled in-person follow-up.
Identifiants
pubmed: 38194133
doi: 10.1007/s10549-023-07232-3
pii: 10.1007/s10549-023-07232-3
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Références
Tomiak E, Piccart M (1993) Routine follow-up of patients after primary therapy for early Breast cancer: changing concepts and challenges for the future. Ann Oncol off J Eur Soc Med Oncol 4:199–204. https://doi.org/10.1093/oxfordjournals.annonc.a058456
doi: 10.1093/oxfordjournals.annonc.a058456
Beltran-Bless A-A, Alshamsan B, Alzahrani MJ et al (2023) Regularly scheduled physical examinations and the detection of Breast cancer recurrences. Breast 69:274–280. https://doi.org/10.1016/j.breast.2023.03.004
doi: 10.1016/j.breast.2023.03.004
pubmed: 36922304
pmcid: 10034490
de Bock GH, Bonnema J, Zwaan RE et al (2004) Patient’s needs and preferences in routine follow-up after treatment for Breast cancer. Br J Cancer 90:1144–1150. https://doi.org/10.1038/sj.bjc.6601655
doi: 10.1038/sj.bjc.6601655
pubmed: 15026793
pmcid: 2409648
Surujballi J, Shah H, Hutton B et al (2021) The COVID-19 pandemic: an opportunity to rethink and harmonise the frequency of follow-up visits for patients with early stage Breast cancer. Cancer Treat Rev 97:102188. https://doi.org/10.1016/j.ctrv.2021.102188
doi: 10.1016/j.ctrv.2021.102188
pubmed: 33813329
pmcid: 7986467
Earle CC, Ganz PA (2012) Cancer survivorship care: don’t let the perfect be the enemy of the good. J Clin Oncol off J Am Soc Clin Oncol 30:3764–3768. https://doi.org/10.1200/JCO.2012.41.7667
doi: 10.1200/JCO.2012.41.7667
Henry NL, Hayes DF, Ramsey SD et al (2014) Promoting quality and evidence-based care in early-stage Breast cancer follow-up. J Natl Cancer Inst 106:dju034. https://doi.org/10.1093/jnci/dju034
doi: 10.1093/jnci/dju034
pubmed: 24627271
pmcid: 4311189
de Bock GH, Bonnema J, van der Hage J et al (2004) Effectiveness of routine visits and routine tests in detecting isolated locoregional recurrences after treatment for early-stage invasive Breast cancer: a meta-analysis and systematic review. J Clin Oncol off J Am Soc Clin Oncol 22:4010–4018. https://doi.org/10.1200/JCO.2004.06.080
doi: 10.1200/JCO.2004.06.080
Schapira DV, Urban N (1991) A minimalist policy for Breast cancer surveillance. JAMA 265:380–382
doi: 10.1001/jama.1991.03460030086034
pubmed: 1984538
National Institute for Healthcare and Excellence Improving outcomes in breast cancer
Cardoso F, Kyriakides S, Ohno S et al (2019) Early Breast cancer: ESMO Clinical Practice guidelines for diagnosis, treatment and follow-up†. Ann Oncol off J Eur Soc Med Oncol 30:1194–1220. https://doi.org/10.1093/annonc/mdz173
doi: 10.1093/annonc/mdz173
Cancer Care Ontario (2010) Cancer Care Ontario’s position. Guidelines for Breast Cancer Well Follow Up Care
National Comprehensive Cancer Network (2023) NCCN Clinical Practice Guidelines in Oncology 2023
Khatcheressian JL, Hurley P, Bantug E et al (2013) Breast cancer follow-up and management after primary treatment: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol off J Am Soc Clin Oncol 31:961–965. https://doi.org/10.1200/JCO.2012.45.9859
doi: 10.1200/JCO.2012.45.9859
Muradali D, Kennedy EB, Eisen A et al (2017) Breast screening for survivors of Breast cancer: a systematic review. Prev Med (Baltim) 103:70–75. https://doi.org/10.1016/j.ypmed.2017.07.026
doi: 10.1016/j.ypmed.2017.07.026
Shah H, Surujballi J, Awan AA et al (2021) A scoping review characterizing choosing Wisely® recommendations for Breast cancer management. Breast Cancer Res Treat 185:533–547. https://doi.org/10.1007/s10549-020-06009-2
doi: 10.1007/s10549-020-06009-2
pubmed: 33156490
American Society of Clinical Oncology (1997) Recommended Breast cancer surveillance guidelines. American Society of Clinical Oncology. J Clin Oncol 15:2149–2156. https://doi.org/10.1200/JCO.1997.15.5.2149
doi: 10.1200/JCO.1997.15.5.2149
Siegel RL, Miller KD, Jemal A (2019) Cancer statistics, 2019. CA Cancer J Clin 69:7–34. https://doi.org/10.3322/caac.21551
doi: 10.3322/caac.21551
pubmed: 30620402
Brenner DR, Weir HK, Demers AA et al (2020) Projected estimates of cancer in Canada in 2020. C Can Med Assoc J = J l’Association Medicale Can 192:E199–E205. https://doi.org/10.1503/cmaj.191292
doi: 10.1503/cmaj.191292
Grunfeld E, Levine MN, Julian JA et al (2006) Randomized trial of long-term follow-up for early-stage Breast cancer: a comparison of family physician versus specialist care. J Clin Oncol off J Am Soc Clin Oncol 24:848–855. https://doi.org/10.1200/JCO.2005.03.2235
doi: 10.1200/JCO.2005.03.2235
European Comission (2019) Expert Panel on effective ways of investing in Health. EXPH)
World Health Organization Taking stock (2008) : Task shifting to tackle health worker shortages:
O’Donovan J, Newcomb A, MacRae MC et al (2020) Community health workers and early detection of Breast cancer in low-income and middle-income countries: a systematic scoping review of the literature. BMJ Glob Heal 5. https://doi.org/10.1136/bmjgh-2020-002466
de Leeuw J, Larsson M (2013) Nurse-led follow-up care for cancer patients: what is known and what is needed. Support care cancer off J Multinatl Assoc Support Care Cancer 21:2643–2649. https://doi.org/10.1007/s00520-013-1892-6
doi: 10.1007/s00520-013-1892-6
Yildiz F, Oksuzoglu B (2020) Teleoncology or telemedicine for oncology patients during the COVID-19 pandemic: the new normal for Breast cancer survivors? Future Oncol 16:2191–2195. https://doi.org/10.2217/fon-2020-0714
doi: 10.2217/fon-2020-0714
pubmed: 32857603
Saunders D, Liu M, Vandermeer L et al (2021) The rethinking clinical trials (REaCT) program. A canadian-led pragmatic trials program: strategies for integrating knowledge users into Trial Design. Curr Oncol 28:3959–3977. https://doi.org/10.3390/curroncol28050337
doi: 10.3390/curroncol28050337
pubmed: 34677255
pmcid: 8534460
Lafranconi A, Pylkkänen L, Deandrea S et al (2017) Intensive follow-up for women with Breast cancer: review of clinical, economic and patient’s preference domains through evidence to decision framework. Health Qual Life Outcomes 15:206. https://doi.org/10.1186/s12955-017-0779-5
doi: 10.1186/s12955-017-0779-5
pubmed: 29052503
pmcid: 5649085
Sisler J, Chaput G, Sussman J, Ozokwelu E (2016) Follow-up after treatment for Breast cancer: practical guide to survivorship care for family physicians. Can Fam Physician 62:805–811
pubmed: 27737976
pmcid: 5063767
Saltbæk L, Karlsen RV, Bidstrup PE et al (2019) MyHealth: specialist nurse-led follow-up in Breast cancer. A randomized controlled trial - development and feasibility. Acta Oncol 58:619–626. https://doi.org/10.1080/0284186X.2018.1563717
doi: 10.1080/0284186X.2018.1563717
pubmed: 30698065
Ankersmid JW, Drossaert CHC, van Riet YEA et al (2022) Needs and preferences of Breast cancer survivors regarding outcome-based shared decision-making about personalised post-treatment surveillance. J Cancer Surviv. https://doi.org/10.1007/s11764-022-01178-z
doi: 10.1007/s11764-022-01178-z
pubmed: 35122224
pmcid: 10442247